Inclusion Criteria:~* Clinical diagnosis of probable AD with supportive brain imaging documentation~* Have
existing neuropsychiatric symptoms as defined by a score equal or greater than 10 on the NPI at screening,
arising from item scores equal or greater than 2 (frequency X severity) on at least 2 domains.~* Has been on
donepezil (stable dose of 5 mg or 10 mg) for at least four months, with no intent to change such for the
duration of the study.~
